SE7705071L - Antitumormedel - Google Patents

Antitumormedel

Info

Publication number
SE7705071L
SE7705071L SE7705071A SE7705071A SE7705071L SE 7705071 L SE7705071 L SE 7705071L SE 7705071 A SE7705071 A SE 7705071A SE 7705071 A SE7705071 A SE 7705071A SE 7705071 L SE7705071 L SE 7705071L
Authority
SE
Sweden
Prior art keywords
antitumor medicine
antitumor
medicine
Prior art date
Application number
SE7705071A
Other languages
English (en)
Swedish (sv)
Inventor
P G Munder
O Westphal
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of SE7705071L publication Critical patent/SE7705071L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE7705071A 1976-05-04 1977-05-02 Antitumormedel SE7705071L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2619686A DE2619686C2 (de) 1976-05-04 1976-05-04 Verwendung eines Lysolecithins zur Tumorbehandlung

Publications (1)

Publication Number Publication Date
SE7705071L true SE7705071L (sv) 1977-11-05

Family

ID=5977045

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7705071A SE7705071L (sv) 1976-05-04 1977-05-02 Antitumormedel

Country Status (15)

Country Link
JP (1) JPS52134027A (xx)
AU (1) AU517586B2 (xx)
BE (1) BE854270A (xx)
CA (1) CA1094455A (xx)
DE (1) DE2619686C2 (xx)
FR (1) FR2364656A1 (xx)
GB (1) GB1583661A (xx)
IE (1) IE44927B1 (xx)
IL (1) IL51988A (xx)
IT (1) IT1071329B (xx)
LU (1) LU77248A1 (xx)
NL (1) NL189672C (xx)
NZ (1) NZ183981A (xx)
SE (1) SE7705071L (xx)
ZA (1) ZA772649B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5396311A (en) * 1977-01-29 1978-08-23 Toyama Chem Co Ltd Anti-cander drugs containing lysolecithins
JPS5528955A (en) * 1978-08-24 1980-02-29 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
EP0050327B1 (de) * 1980-10-21 1984-06-20 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
DE3127503A1 (de) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3131524A1 (de) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung physiologischer effektoren
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
EP0103877B1 (en) * 1982-09-21 1987-01-07 Fujisawa Pharmaceutical Co., Ltd. Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
DE3662197D1 (en) 1985-07-15 1989-04-06 Takeda Chemical Industries Ltd 2-alkanoyloxypropane derivatives, their production and use
JPS6294A (ja) * 1986-05-09 1987-01-06 Toyama Chem Co Ltd 新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
DE3935580C2 (de) * 1989-10-25 1998-05-28 Medmark Pharma Gmbh Verwendung eines pharmazeutischen Wirkstoffes zur Behandlung von HIV-Infektionen
EP0581793A1 (en) * 1991-04-25 1994-02-09 University Of British Columbia Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
ES2034885B1 (es) * 1991-07-10 1994-03-01 Menarini Lab Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
KR100381449B1 (ko) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 에테르지질리포좀과이들의제약학적용도
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5965159A (en) 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6135426A (en) * 1998-01-07 2000-10-24 Briggs And Stratton Corporation Priming system for internal combustion engines
EP2091520B1 (en) 2006-11-10 2012-02-22 Alphaptose Gmbh Oral dosage form comprising tri-substituted glycerol compounds
CN101606061B (zh) * 2006-11-10 2014-01-22 阿尔法普托斯有限公司 用于检测受体配体模拟物的方法和组合物
US8637688B2 (en) * 2006-12-20 2014-01-28 Julia Diederichs Topical dosage form comprising tri-substituted glycerol compounds
US20100136029A1 (en) * 2006-12-20 2010-06-03 Universitatsklinikum Hamburg-Eppendorf Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009342C3 (de) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
DE2009341C3 (de) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
DE2033361C3 (de) * 1970-07-06 1980-02-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Acylpropandiol-(13)-phosphorsäurecholinester und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
LU77248A1 (xx) 1977-12-13
IL51988A (en) 1981-05-20
CA1094455A (en) 1981-01-27
ZA772649B (en) 1978-04-26
JPS52134027A (en) 1977-11-09
DE2619686A1 (de) 1977-11-24
NZ183981A (en) 1980-04-28
IL51988A0 (en) 1977-07-31
DE2619686C2 (de) 1986-08-07
IE44927L (en) 1977-11-04
IE44927B1 (en) 1982-05-19
JPS6146455B2 (xx) 1986-10-14
IT1071329B (it) 1985-04-02
NL7704723A (nl) 1977-11-08
FR2364656A1 (fr) 1978-04-14
NL189672B (nl) 1993-01-18
NL189672C (nl) 1993-06-16
AU517586B2 (en) 1981-08-13
FR2364656B1 (xx) 1980-03-07
AU2481977A (en) 1978-11-09
GB1583661A (en) 1981-01-28
BE854270A (fr) 1977-11-04

Similar Documents

Publication Publication Date Title
SE7705071L (sv) Antitumormedel
DK589576A (da) Formbevarende ble
DK154399C (da) Inhalationsapparat
DK153523C (da) Inhalationsapparat
IT1075111B (it) Catetere
SE426652B (sv) Spruta
SE7700722L (sv) Kateter
AT356798B (de) Katheteransatz
SE431935B (sv) Sett att framstella drageer
PT67011B (pt) Lichtemfindliche kopiermasse auf diazobasis
SE426431B (sv) Polomkopplingsbar trefaslindning
BR7600226A (pt) Conjunto de medicao
SE7611326L (sv) Givare
DK150477A (da) Kanyle
SE7714826L (sv) Aviveringsmedel
SE7807987L (sv) Anti-tumormedel
SE7705729L (sv) Tomografi
SE7706007L (sv) Tomografi
FI772531A (fi) Patientbrits
FI763506A (fi) Farmaceutisk naeringsfoerpackning
FI773812A (fi) Farmaceutiska foereningar
IT1084116B (it) Complesso costipatore
ATA280377A (de) Unmagnetische tretmine
SE7812198L (sv) Antitumormedel
FI773813A (fi) Farmaceutiska foereningar